@article{5277bfc30fd24775abe471ed9773dba7,
title = "NICE guidance on pixantrone monotherapy for multiply relapsed or refractory aggressive non-Hodgkin lymphoma",
keywords = "Cost-Benefit Analysis, Drug Approval, Drug Costs, Drug Resistance, Neoplasm, Evidence-Based Medicine, Humans, Isoquinolines, Lymphoma, Non-Hodgkin, Practice Guidelines as Topic, Recurrence, Topoisomerase II Inhibitors, Treatment Outcome",
author = "Landells, {Linda J} and Carl Prescott and Nicola Hay and Frances Sutcliffe and Andrew Stevens",
year = "2014",
month = apr,
doi = "10.1016/S1470-2045(14)70089-0",
language = "English",
volume = "15",
pages = "381--382",
journal = "The Lancet Oncology",
issn = "1470-2045",
publisher = "Elsevier",
number = "4",
}